APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease

Animal and human studies support a role for apolipoprotein A-V (apoA-V) in triglyceride (TG) metabolism. We examined the relationship of APOA5 −1131T>C and S19W with lipid subfractions and progression of atherosclerosis in the Lopid Coronary Angiography Trial. Compared with −1131TT men (n = 242),...

Full description

Bibliographic Details
Main Authors:	Philippa J. Talmud, Steve Martin, Marja-Riitta Taskinen, M. Heikki Frick, Markku S. Nieminen, Y. Antero Kesäniemi, Amos Pasternack, Steve E. Humphries, Mikko Syvänne
Format:	Article
Language:	English
Published:	Elsevier 2004-04-01
Series:	Journal of Lipid Research
Subjects:	apolipoprotein A-V lipid subfractions very low density lipoprotein intermediate density lipoprotein progression of atherogenesis Lopid Coronary Angiography Trial
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520318605

Similar Items

Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study
by: Piotr Chruściel, et al.
Published: (2019-06-01)

Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic
by: Hsin-hung Chen, et al.
Published: (2007-01-01)

The APOA4 T347S variant is associated with reduced plasma TAOS in subjects with diabetes mellitus and cardiovascular disease
by: Wai-man R. Wong, et al.
Published: (2004-08-01)

SR-BI-mediated selective lipid uptake segregates apoA-I and apoA-II catabolism
by: Maria C. de Beer, et al.
Published: (2005-10-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Association of high-density lipoprotein cholesterol subfractions with insulin resistance in Nigerians with type 2 diabetes mellitus
by: Chikezie Hart Onwukwe, et al.
Published: (2021-01-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
by: Michael B. Boffa, et al.
Published: (2016-05-01)

Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
by: Chih-Kuo Lee, et al.
Published: (2021-08-01)

High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
by: Knut Tore Lappegård, et al.
Published: (2021-07-01)

Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01)

ApoA-I-Mediated Lipoprotein Remodeling Monitored with a Fluorescent Phospholipid
by: Edward B. Neufeld, et al.
Published: (2019-07-01)

Model class A and class L peptides increase the production of apoA-I-containing lipoproteins in HepG2 cells
by: Nassrin Dashti, et al.
Published: (2004-10-01)

The relationship between insulin resistance and ion mobility lipoprotein fractions
by: Charles M. Rowland, et al.
Published: (2023-03-01)

N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL
by: Alexandros D. Tselepis, et al.
Published: (2001-10-01)

Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients
by: Hajnalka Lőrincz, et al.
Published: (2023-11-01)

Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor
by: Danijela Lucic, et al.
Published: (2007-02-01)

Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice
by: Jacinta M. Letters, et al.
Published: (1999-06-01)

Plasma apolipoprotein O level increased in the patients with acute coronary syndrome
by: Bi-lian Yu, et al.
Published: (2012-09-01)

Dietary fat modulation of apoA-II metabolism and prevention of senile amyloidosis in the senescence- accelerated mouse
by: Makiko Umezawa, et al.
Published: (2003-04-01)

Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome
by: Guohua Song, et al.
Published: (2013-07-01)

Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma
by: David Meriwether, et al.
Published: (2011-10-01)

LDL particle size in familial combined hyperlipidemia: effects of serum lipids, lipoprotein-modifying enzymes, and lipid transfer proteins
by: Juha Vakkilainen, et al.
Published: (2002-04-01)

Circulating HDL levels control hypothalamic astrogliosis via apoA-I
by: Anna Götz, et al.
Published: (2018-09-01)

ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia
by: Jesús M. Martín-Campos, et al.
Published: (2002-01-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding
by: Allan D. Sniderman, et al.
Published: (2018-01-01)

Effects of reconstituted HDL on charge-based LDL subfractions as characterized by capillary isotachophoresis
by: Zhang Bo, et al.
Published: (2007-05-01)

Abnormal HDL lipid and protein composition following pediatric cancer treatment: an associative study
by: Véronique Bélanger, et al.
Published: (2023-06-01)

Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques[S]
by: G.M. Anantharamaiah, et al.
Published: (2018-11-01)

Serum lipoprotein accumulation in the livers of orotic acid-fed rats
by: LAWRENCE A. POTTENGER, et al.
Published: (1971-07-01)

ApoE genotype-specific inhibition of apoptosis
by: Robert M. DeKroon, et al.
Published: (2003-08-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy[S]
by: Ariel Brautbar, et al.
Published: (2013-07-01)

Developing Electron Microscopy Tools for Profiling Plasma Lipoproteins Using Methyl Cellulose Embedment, Machine Learning and Immunodetection of Apolipoprotein B and Apolipoprotein(a)
by: Yvonne Giesecke, et al.
Published: (2020-09-01)

Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a review
by: C. Roger White, et al.
Published: (2014-10-01)

High-Density Lipoprotein and Heart Failure
by: Liyun Xing, et al.
Published: (2023-11-01)

Enhancement of High-Density Lipoprotein (HDL) Quantity and Quality by Regular and Habitual Exercise in Middle-Aged Women with Improvements in Lipid and Apolipoprotein Profiles: Larger Particle Size and Higher Antioxidant Ability of HDL
by: Kyung-Hyun Cho, et al.
Published: (2023-01-01)